A Phase 2 interventional study of intranasal octreotide in diabetic macular edema
Not Yet Recruiting Phase 1 NCT06881888
Study Description
Evaluating the effectiveness and safety of intranasal octreotide in treating diabetic macular edema
Study Details
- Registry ID:
- NCT06881888
- Conditions:
- Diabetic Macular Edema
- Phase:
- Phase 1
- Target Enrollment:
- 60 participants
- Start Date:
- Age Range:
- 18–90 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
The University of Alabama at Birmingham
Birmingham, Alabama, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.